CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 70 filers reported holding CASI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $369,005 | -34.9% | 206,148 | -5.5% | 0.04% | -66.7% |
| Q3 2022 | $567,000 | -7.0% | 218,247 | +2.3% | 0.14% | +77.6% |
| Q2 2022 | $610,000 | -64.7% | 213,250 | -90.0% | 0.08% | -59.8% |
| Q1 2022 | $1,727,000 | -1.4% | 2,132,547 | -2.6% | 0.19% | -15.6% |
| Q4 2021 | $1,751,000 | -34.8% | 2,188,547 | -3.1% | 0.22% | -39.0% |
| Q3 2021 | $2,687,000 | -23.2% | 2,258,265 | +0.0% | 0.37% | -13.2% |
| Q2 2021 | $3,500,000 | -34.7% | 2,258,264 | +1.2% | 0.42% | -16.9% |
| Q1 2021 | $5,356,000 | -12.4% | 2,231,765 | +7.7% | 0.51% | -37.8% |
| Q4 2020 | $6,112,000 | +180.4% | 2,071,765 | +45.4% | 0.82% | +136.4% |
| Q3 2020 | $2,180,000 | -34.0% | 1,424,731 | +7.8% | 0.35% | -34.7% |
| Q2 2020 | $3,304,000 | +23.1% | 1,321,745 | +0.5% | 0.53% | +4.5% |
| Q1 2020 | $2,684,000 | -34.0% | 1,315,577 | 0.0% | 0.51% | -18.9% |
| Q4 2019 | $4,065,000 | -7.4% | 1,315,577 | +0.0% | 0.62% | -12.6% |
| Q3 2019 | $4,392,000 | +20.3% | 1,315,077 | +15.2% | 0.72% | +18.2% |
| Q2 2019 | $3,652,000 | +11.0% | 1,141,237 | -0.4% | 0.60% | +8.0% |
| Q1 2019 | $3,289,000 | -30.5% | 1,145,949 | -2.6% | 0.56% | -37.4% |
| Q4 2018 | $4,732,000 | +14.1% | 1,177,131 | +32.5% | 0.89% | +33.6% |
| Q3 2018 | $4,149,000 | -41.0% | 888,333 | +3.9% | 0.67% | -42.5% |
| Q2 2018 | $7,037,000 | +113.6% | 855,056 | +8.2% | 1.16% | +133.5% |
| Q1 2018 | $3,295,000 | +39.8% | 790,256 | +8.9% | 0.50% | +36.1% |
| Q4 2017 | $2,357,000 | +83.6% | 725,348 | 0.0% | 0.37% | +73.5% |
| Q3 2017 | $1,284,000 | +68.5% | 725,348 | -0.1% | 0.21% | +70.2% |
| Q2 2017 | $762,000 | -26.3% | 726,069 | -0.3% | 0.12% | -25.7% |
| Q1 2017 | $1,034,000 | +70.1% | 728,447 | +37.8% | 0.17% | +65.3% |
| Q4 2016 | $608,000 | -1.8% | 528,447 | -5.2% | 0.10% | -6.5% |
| Q3 2016 | $619,000 | -5.8% | 557,268 | -0.7% | 0.11% | -2.7% |
| Q2 2016 | $657,000 | +10.4% | 561,408 | 0.0% | 0.11% | +6.7% |
| Q1 2016 | $595,000 | +33.1% | 561,408 | +20.6% | 0.10% | +36.8% |
| Q4 2015 | $447,000 | -29.2% | 465,359 | -21.1% | 0.08% | -30.3% |
| Q3 2015 | $631,000 | -40.4% | 589,859 | -0.3% | 0.11% | -32.7% |
| Q2 2015 | $1,059,000 | +21.4% | 591,695 | 0.0% | 0.16% | +23.7% |
| Q1 2015 | $872,000 | +14.7% | 591,695 | +3.5% | 0.13% | +8.3% |
| Q4 2014 | $760,000 | -50.2% | 571,695 | -32.9% | 0.12% | -52.2% |
| Q3 2014 | $1,525,000 | +9.3% | 851,705 | +9.9% | 0.25% | +16.1% |
| Q2 2014 | $1,395,000 | – | 775,155 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |